Chinese medicines have been proven to have the effect of anti-inflammatory, antioxidant, and lipid homeostasis, and improving insulin sensitivity may be a potential strategy for NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.